189 related articles for article (PubMed ID: 37917328)
21. Effect of Montelukast on Bronchopulmonary Dysplasia (BPD) and Related Mechanisms.
Chen X; Zhang X; Pan J
Med Sci Monit; 2019 Mar; 25():1886-1893. PubMed ID: 30862773
[TBL] [Abstract][Full Text] [Related]
22. ETS1 Ameliorates Hyperoxia-Induced Bronchopulmonary Dysplasia in Mice by Activating Nrf2/HO-1 Mediated Ferroptosis.
Yang M; Chen Y; Huang X; Shen F; Meng Y
Lung; 2023 Aug; 201(4):425-441. PubMed ID: 37490064
[TBL] [Abstract][Full Text] [Related]
23. Bone Marrow Stromal Cell-Secreted Extracellular Vesicles Containing miR-34c-5p Alleviate Lung Injury and Inflammation in Bronchopulmonary Dysplasia Through Promotion of PTEN Degradation by Targeting OTUD3.
He X; Kuang J; Wang Y; Lan G; Shi X
Immunol Invest; 2023 Nov; 52(6):681-702. PubMed ID: 37310728
[TBL] [Abstract][Full Text] [Related]
24. SIRT3 improves alveolar epithelial cell damage caused by bronchopulmonary dysplasia through deacetylation of FOXO1.
Zang L; Chi J; Bi S; Tao Y; Wang R; Li L
Allergol Immunopathol (Madr); 2023; 51(2):191-204. PubMed ID: 36916106
[TBL] [Abstract][Full Text] [Related]
25. Targeting p16
Zysman M; Baptista BR; Essari LA; Taghizadeh S; Thibault de Ménonville C; Giffard C; Issa A; Franco-Montoya ML; Breau M; Souktani R; Aissat A; Caeymaex L; Lizé M; Van Nhieu JT; Jung C; Rottier R; Cruzeiro MD; Adnot S; Epaud R; Chabot F; Lanone S; Boczkowski J; Boyer L
Am J Respir Crit Care Med; 2020 Oct; 202(8):1088-1104. PubMed ID: 32628504
[No Abstract] [Full Text] [Related]
26. Immune System Regulation Affected by a Murine Experimental Model of Bronchopulmonary Dysplasia: Genomic and Epigenetic Findings.
Revhaug C; Bik-Multanowski M; Zasada M; Rognlien AGW; Günther CC; Ksiązek T; Madetko-Talowska A; Szewczyk K; Grabowska A; Kwinta P; Pietrzyk JJ; Baumbusch LO; Saugstad OD
Neonatology; 2019; 116(3):269-277. PubMed ID: 31454811
[TBL] [Abstract][Full Text] [Related]
27. Foxm1 regulates resolution of hyperoxic lung injury in newborns.
Xia H; Ren X; Bolte CS; Ustiyan V; Zhang Y; Shah TA; Kalin TV; Whitsett JA; Kalinichenko VV
Am J Respir Cell Mol Biol; 2015 May; 52(5):611-21. PubMed ID: 25275225
[TBL] [Abstract][Full Text] [Related]
28. CD11b(+) Mononuclear Cells Mitigate Hyperoxia-Induced Lung Injury in Neonatal Mice.
Eldredge LC; Treuting PM; Manicone AM; Ziegler SF; Parks WC; McGuire JK
Am J Respir Cell Mol Biol; 2016 Feb; 54(2):273-83. PubMed ID: 26192732
[TBL] [Abstract][Full Text] [Related]
29. Human breast milk-derived exosomes through inhibiting AT II cell apoptosis to prevent bronchopulmonary dysplasia in rat lung.
Zhou Y; Liu Y; Xu G; Liu L; Li H; Li Y; Yin J; Wang X; Yu Z
J Cell Mol Med; 2022 Aug; 26(15):4169-4182. PubMed ID: 35833257
[TBL] [Abstract][Full Text] [Related]
30. Does Chrysin prevent severe lung damage in Hyperoxia-Induced lung injury Model?
Ozdemir R; Gokce IK; Taslidere AC; Tanbek K; Gul CC; Sandal S; Turgut H; Kaya H; Aslan M
Int Immunopharmacol; 2021 Oct; 99():108033. PubMed ID: 34343938
[TBL] [Abstract][Full Text] [Related]
31. Hyperoxia-induced bronchopulmonary dysplasia: better models for better therapies.
Giusto K; Wanczyk H; Jensen T; Finck C
Dis Model Mech; 2021 Feb; 14(2):. PubMed ID: 33729989
[TBL] [Abstract][Full Text] [Related]
32. SEMA3A protects against hyperoxia-induced lung injury in a bronchopulmonary dysplasia model of newborn rat by inhibiting ERK pathway.
Liang Z; Zhang X; Liu Y; Wu Q; You C
Allergol Immunopathol (Madr); 2021; 49(6):8-15. PubMed ID: 34761651
[TBL] [Abstract][Full Text] [Related]
33. IRF4-mediated Treg phenotype switching can aggravate hyperoxia-induced alveolar epithelial cell injury.
Langyue H; Ying Z; Jianfeng J; Yue Z; Huici Y; Hongyan L
BMC Pulm Med; 2024 Mar; 24(1):130. PubMed ID: 38491484
[TBL] [Abstract][Full Text] [Related]
34. Caffeine prevents hyperoxia-induced lung injury in neonatal mice through NLRP3 inflammasome and NF-κB pathway.
Chen S; Wu Q; Zhong D; Li C; Du L
Respir Res; 2020 Jun; 21(1):140. PubMed ID: 32513156
[TBL] [Abstract][Full Text] [Related]
35. Hyperoxia-induced lung injury increases CDKN1A levels in a newborn rat model of bronchopulmonary dysplasia.
Pan YQ; Hou AN
Exp Lung Res; 2018; 44(8-9):424-432. PubMed ID: 30755044
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-1 receptor antagonist prevents murine bronchopulmonary dysplasia induced by perinatal inflammation and hyperoxia.
Nold MF; Mangan NE; Rudloff I; Cho SX; Shariatian N; Samarasinghe TD; Skuza EM; Pedersen J; Veldman A; Berger PJ; Nold-Petry CA
Proc Natl Acad Sci U S A; 2013 Aug; 110(35):14384-9. PubMed ID: 23946428
[TBL] [Abstract][Full Text] [Related]
37. SOX4 arrests lung development in rats with hyperoxia‑induced bronchopulmonary dysplasia by controlling EZH2 expression.
Pan B; Xue X; Zhang D; Li M; Fu J
Int J Mol Med; 2017 Dec; 40(6):1691-1698. PubMed ID: 29039454
[TBL] [Abstract][Full Text] [Related]
38. Hyperoxia causes miR199a-5p-mediated injury in the developing lung.
Alam MA; Betal SGN; Aghai ZH; Bhandari V
Pediatr Res; 2019 Nov; 86(5):579-588. PubMed ID: 31390652
[TBL] [Abstract][Full Text] [Related]
39. Melatonin Protects Against Hyperoxia-Induced Apoptosis in Alveolar Epithelial type II Cells by Activating the MT2/PI3K/AKT/ETS1 Signaling Pathway.
He F; Wang QF; Li L; Yu C; Liu CZ; Wei WC; Chen LP; Li HY
Lung; 2023 Apr; 201(2):225-234. PubMed ID: 36928143
[TBL] [Abstract][Full Text] [Related]
40. Hyperoxia-induced miR-342-5p down-regulation exacerbates neonatal bronchopulmonary dysplasia via the Raf1 regulator Spred3.
Wen X; Zhang H; Xiang B; Zhang W; Gong F; Li S; Chen H; Luo X; Deng J; You Y; Hu Z; Jiang C
Br J Pharmacol; 2021 Jun; 178(11):2266-2283. PubMed ID: 33434946
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
